Sort
8,912 grants matching “sars cov 2”
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
$580,295Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Role of RNA modifications in coronaviruses replication
$580,294Marcos Morgan · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES - SARS-CoV-2 RESEARCH
$580,155Peter Myler · Seattle Children'S Hospital · N01 · FY2020 · AI
COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants
$579,524Ousseny Zerbo · Kaiser Foundation Research Institute · R01 · FY2022 · AI
Statistical adjustments of sample representation in community-level estimates of COVID-19 transmission and immunity
$578,172Yajuan Si · University Of Michigan At Ann Arbor · U01 · FY2022 · MD
Kinetic and structural basis for SARS-CoV-2 RNA-dependent RNA polymerase specificity and inhibition
$577,840Kenneth Allen Johnson · University Of Texas At Austin · R01 · FY2021 · AI
Kinetic and structural basis for SARS-CoV-2 RNA-dependent RNA polymerase specificity and inhibition
$577,840Kenneth Allen Johnson · University Of Texas At Austin · R01 · FY2023 · AI
Kinetic and structural basis for SARS-CoV-2 RNA-dependent RNA polymerase specificity and inhibition
$577,840Kenneth Allen Johnson · University Of Texas At Austin · R01 · FY2022 · AI
Severity and long-term health effects of COVID-19 among World Trade Center responders
$577,266Benjamin J Luft · State University New York Stony Brook · U01 · FY2025 · OH
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
$577,202Ute M Moll · State University New York Stony Brook · R01 · FY2022 · HL
Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)
$576,575Elliott D Crouser · Ohio State University · U01 · FY2022 · AI
Understanding the Risk of Bat Coronavirus Emergence
$576,290Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2023 · AI
Quantitative histopathology for cancer prognosis using quantitative phase imaging on stained tissues
$576,268Gabriel Popescu · University Of Illinois At Urbana-Champaign · R01 · FY2021 · CA
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach
$576,184David Huw Davies · University Of California-Irvine · U01 · FY2024 · AI
TRANSFORMATIVE LIPID EXCHANGE APPROACHES TO STUDY MEMBRANE ORGANIZATION
$576,160Erwin London · State University New York Stony Brook · R35 · FY2025 · GM
TRANSFORMATIVE LIPID EXCHANGE APPROACHES TO STUDY MEMBRANE ORGANIZATION
$576,160Erwin London · State University New York Stony Brook · R35 · FY2024 · GM
Identification and Dynamics of SARS-CoV-2 Sequence Variants in Idaho
$576,000Dennis L Stevens · Idaho Veterans Research / Education Fdn · P20 · FY2021 · GM
Therapeutics targeting cathepsin-activated viral entry
$575,911Paul F Bates · University Of Pennsylvania · U01 · FY2007 · AI
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach
$575,733David Huw Davies · University Of California-Irvine · U01 · FY2022 · AI
Individualized Prediction of Treatment Effects Using Data from Both Embedded Clinical Trials and Electronic Health Records
$575,480Gregory F Cooper · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
PRECISE: accessible sample-to-answer RT-PCR detection of hepatitis C infection from whole blood
$575,356Samuel K Sia · Columbia University Health Sciences · R01 · FY2025 · AI
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$575,015Michael R Wilson · University Of California, San Francisco · R01 · FY2024 · NS
The mutational landscape of SARS-CoV-2 nucleocapsid protein
$574,875Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2024 · EB
Mass Spectrometry Characterization
$574,792Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Identification, structures and ontogenies of SARS-CoV-2 antibodies
$574,748Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI